The burden of atopic dermatitis and bacterial skin infections among urban-living Indigenous children and young people in high-income countries: A systematic review.
atopic dermatitis
bacterial skin diseases
children
epidemiology
high-income population
indigenous population
urban population
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
28
06
2022
accepted:
20
09
2022
pubmed:
10
11
2022
medline:
25
1
2023
entrez:
9
11
2022
Statut:
ppublish
Résumé
A high burden of bacterial skin infections (BSI) is well documented in remote-living Indigenous children and young people (CYP) in high-income countries (HIC). Atopic dermatitis (AD) is the most common chronic inflammatory skin condition seen in CYP and predisposes to BSI. Despite the rate of urbanization for Indigenous people increasing globally, research is lacking on the burden of AD and BSI for urban-living Indigenous CYP in HIC. Indigenous people in HIC share a history of colonization, displacement and subsequent ongoing negative impacts on health. To provide a global background on the burden of AD and BSI in urban-living Indigenous CYP in HIC. A systematic review of primary observational studies on AD and BSI in English containing epidemiologic data was performed. MEDLINE, EMBASE, EMCARE, Web of Science, and PubMed databases were searched for articles between January 1990 and December 2021. From 2278 original manuscripts, 16 were included: seven manuscripts documenting eight studies on AD; and nine manuscripts documenting nine studies on BSI. Current and severe symptoms of AD were more common in urban-living Indigenous CYP in HIC compared with their non-Indigenous peers, with children having a higher prevalence than adolescents. Urban-living Indigenous CYP in HIC had a higher incidence of all measures of BSI compared with their non-Indigenous peers, and were over-represented for all measures of BSI compared with their proportion of the background population. Limitations include incomplete representation of all Indigenous populations in HIC. A significant burden of AD and BSI exists in urban-living Indigenous CYP in HIC.
Sections du résumé
BACKGROUND
BACKGROUND
A high burden of bacterial skin infections (BSI) is well documented in remote-living Indigenous children and young people (CYP) in high-income countries (HIC). Atopic dermatitis (AD) is the most common chronic inflammatory skin condition seen in CYP and predisposes to BSI. Despite the rate of urbanization for Indigenous people increasing globally, research is lacking on the burden of AD and BSI for urban-living Indigenous CYP in HIC. Indigenous people in HIC share a history of colonization, displacement and subsequent ongoing negative impacts on health.
OBJECTIVE
OBJECTIVE
To provide a global background on the burden of AD and BSI in urban-living Indigenous CYP in HIC.
METHODS
METHODS
A systematic review of primary observational studies on AD and BSI in English containing epidemiologic data was performed. MEDLINE, EMBASE, EMCARE, Web of Science, and PubMed databases were searched for articles between January 1990 and December 2021.
RESULTS
RESULTS
From 2278 original manuscripts, 16 were included: seven manuscripts documenting eight studies on AD; and nine manuscripts documenting nine studies on BSI. Current and severe symptoms of AD were more common in urban-living Indigenous CYP in HIC compared with their non-Indigenous peers, with children having a higher prevalence than adolescents. Urban-living Indigenous CYP in HIC had a higher incidence of all measures of BSI compared with their non-Indigenous peers, and were over-represented for all measures of BSI compared with their proportion of the background population. Limitations include incomplete representation of all Indigenous populations in HIC.
CONCLUSION
CONCLUSIONS
A significant burden of AD and BSI exists in urban-living Indigenous CYP in HIC.
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35-43Subventions
Organisme : Australian Government Research Training Program
Organisme : The Australian National Health and Medical Research Council (NHMRC)
Organisme : Wesfarmers Centre of Vaccines & Infectious Diseases
Informations de copyright
© 2022 The Authors. Pediatric Dermatology published by Wiley Periodicals LLC.
Références
Acta Derm Venereol. 2005;85(2):140-3
pubmed: 15823908
N Z Med J. 2012 Mar 09;125(1351):55-69
pubmed: 22426611
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Paediatr Child Health. 2017 Jul;53(7):636-643
pubmed: 28436124
PLoS One. 2017 Nov 30;12(11):e0188803
pubmed: 29190667
Pediatr Dermatol. 2021 Nov;38 Suppl 2:188-189
pubmed: 34850439
J Dev Orig Health Dis. 2019 Feb;10(1):115-122
pubmed: 30223914
PLoS One. 2015 Aug 28;10(8):e0136789
pubmed: 26317533
Pediatr Dermatol. 2023 Jan;40(1):35-43
pubmed: 36349531
Pediatr Dermatol. 2019 Jan;36(1):66-71
pubmed: 30556595
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
BMJ Paediatr Open. 2021 Jul 16;5(1):e001130
pubmed: 34337163
Lancet. 2009 Jul 4;374(9683):76-85
pubmed: 19577696
Pediatr Infect Dis J. 2013 Aug;32(8):923-5
pubmed: 23518822
Allergy Asthma Clin Immunol. 2018 Feb 27;14:9
pubmed: 29492095
Western Pac Surveill Response J. 2017 Dec 12;8(4):6-12
pubmed: 29487758
Asia Pac Allergy. 2013 Jul;3(3):161-78
pubmed: 23956963
J Paediatr Child Health. 2013 Feb;49(2):141-3
pubmed: 23347222
J Paediatr Child Health. 2003 Sep-Oct;39(7):534-9
pubmed: 12969209
Ann Allergy Asthma Immunol. 2021 Apr;126(4):417-428.e2
pubmed: 33421555
Br J Dermatol. 2020 Jun;182(6):1331-1342
pubmed: 31677162
Syst Rev. 2022 Aug 9;11(1):159
pubmed: 35945624
Med J Aust. 2020 Mar;212(5):231-237
pubmed: 31630410
Br J Dermatol. 2010 May;162(5):964-73
pubmed: 20331459
Acta Paediatr. 2001 Sep;90(9):982-8
pubmed: 11683210
Australas J Dermatol. 2018 Aug;59(3):194-200
pubmed: 28752615
Allergy Asthma Clin Immunol. 2019 Apr 23;15:26
pubmed: 31043967
Lancet Reg Health West Pac. 2021 Feb 05;8:100101
pubmed: 34327427
J Paediatr Child Health. 2019 Feb;55(2):224-228
pubmed: 30161281
Nat Rev Dis Primers. 2018 Jun 21;4(1):1
pubmed: 29930242